Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Risaralda, Colombia.
Grupo de Investigación Biomedicina, Facultad de Medicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia.
PLoS One. 2021 Nov 19;16(11):e0260169. doi: 10.1371/journal.pone.0260169. eCollection 2021.
Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide, and several sociodemographic variables, comorbidities and care variables have been associated with complications and mortality.
To identify the factors associated with admission to intensive care units (ICUs) and mortality in patients with COVID-19 from 4 clinics in Colombia.
This was a follow-up study of a cohort of patients diagnosed with COVID-19 between March and August 2020. Sociodemographic, clinical (Charlson comorbidity index and NEWS 2 score) and pharmacological variables were identified. Multivariate analyses were performed to identify variables associated with the risk of admission to the ICU and death (p<0.05).
A total of 780 patients were analyzed, with a median age of 57.0 years; 61.2% were male. On admission, 54.9% were classified as severely ill, 65.3% were diagnosed with acute respiratory distress syndrome, 32.4% were admitted to the ICU, and 26.0% died. The factors associated with a greater likelihood of ICU admission were severe pneumonia (OR: 9.86; 95%CI:5.99-16.23), each 1-point increase in the NEWS 2 score (OR:1.09; 95%CI:1.002-1.19), history of ischemic heart disease (OR:3.24; 95%CI:1.16-9.00), and chronic obstructive pulmonary disease (OR:2.07; 95%CI:1.09-3.90). The risk of dying increased in those older than 65 years (OR:3.08; 95%CI:1.66-5.71), in patients with acute renal failure (OR:6.96; 95%CI:4.41-11.78), admitted to the ICU (OR:6.31; 95%CI:3.63-10.95), and for each 1-point increase in the Charlson comorbidity index (OR:1.16; 95%CI:1.002-1.35).
Factors related to increasing the probability of requiring ICU care or dying in patients with COVID-19 were identified, facilitating the development of anticipatory intervention measures that favor comprehensive care and improve patient prognosis.
2019 年冠状病毒病(COVID-19)已在全球范围内影响了数百万人,有几个社会人口学变量、合并症和护理变量与并发症和死亡率相关。
确定与哥伦比亚 4 家诊所的 COVID-19 患者入住重症监护病房(ICU)和死亡相关的因素。
这是对 2020 年 3 月至 8 月间诊断为 COVID-19 的患者队列进行的随访研究。确定了社会人口统计学、临床(Charlson 合并症指数和 NEWS2 评分)和药理学变量。进行多变量分析以确定与入住 ICU 和死亡风险相关的变量(p<0.05)。
共分析了 780 例患者,中位年龄为 57.0 岁;61.2%为男性。入院时,54.9%为重症患者,65.3%被诊断为急性呼吸窘迫综合征,32.4%入住 ICU,26.0%死亡。与更有可能入住 ICU 相关的因素包括严重肺炎(OR:9.86;95%CI:5.99-16.23)、NEWS2 评分每增加 1 分(OR:1.09;95%CI:1.002-1.19)、缺血性心脏病史(OR:3.24;95%CI:1.16-9.00)和慢性阻塞性肺疾病(OR:2.07;95%CI:1.09-3.90)。65 岁以上(OR:3.08;95%CI:1.66-5.71)、急性肾衰竭(OR:6.96;95%CI:4.41-11.78)、入住 ICU(OR:6.31;95%CI:3.63-10.95)和 Charlson 合并症指数每增加 1 分(OR:1.16;95%CI:1.002-1.35)的患者死亡风险增加。
确定了与 COVID-19 患者需要 ICU 护理或死亡概率增加相关的因素,这有助于制定预期干预措施,有利于全面护理并改善患者预后。